glycopyrrolate
| Form | Strength |
|---|---|
| SOLUTION, INJECTABLE | 0.2 mg/1 mL; 1 mg/5 mL |
| TABLET, ORAL | 1 mg |
| Per policy, orders for these non-formulary agents will be changed to formulary equivalents. | |
|---|---|
| Non-Formulary Agent | Formulary Equivalent |
| glycopyrolate (Seebri Neohaler, Lonhala Magnair) | ipratropium (Atrovent) nebs 0.5 mg q6h |